A Study of AMDX-2011P in Participants With Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer\'s Disease (AD).
Epistemonikos ID: 027f08bab265bd6c3c71a8ee6be8e6b632d6e5d1
First added on: Aug 01, 2024